Parkinson's Disease Trial, Not Yet Recruiting NCT07702929 Sponsor: Isfahan University of Medical Sciences Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT07702929
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • A neurologist has diagnosed the person with Parkinson's disease using a recognised set of international diagnostic guidelines.
  • The person is between 45 and 65 years old.
  • The person was first diagnosed with Parkinson's disease at least 2 years ago but no more than 10 years ago.
  • The person has a disability level of 3 or lower on a standard Parkinson's rating scale, meaning they are still physically independent (confirm with trial site).
  • The person has mild thinking or memory difficulties, shown by a score of between 20 and 26 on a standard cognitive assessment tool called the Montreal Cognitive Assessment.
  • The person has agreed to take part by signing a written consent form.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a neurological condition other than Parkinson's disease.
  • People who have bone, joint, or internal health conditions that would make it hard to take part in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hamid Reza Rostami, PhD, Isfahan University of Medical Sciences

Phone: 00989134328034

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Isfahan University of Medical Sciences
Registry
ClinicalTrials.gov
Start date
23 August 2026
Est. completion
23 July 2027

Primary endpoints

Montreal Cognitive Assessment; Cambridge Neuropsychological Test Automated Battery - Reaction Time; Cambridge Neuropsychological Test Automated Battery - Spatial Span Test; Cambridge Neuropsychological Test Automated Battery - Match to Sample Visual Search Test; Cambridge Neuropsychological Test Automated Battery - Stop Signal Task; KING'S PD Pain Scale; Box & Block Test; The Purdue Pegboard Test; Hand Dynamometer Hydraulic Jamar; Pinch gauge; Semmes-Weinstein monofilaments; The Michigan Hand Outcome Questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov